Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Primary Myelofibrosis × selinexor × Clear all

Status

Sponsor Class

Study Type

Interventional 1 Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1 Plasma cell 1 Myeloid 1 Lymphoid 1 Gynecologic 1

Conditions

Multiple Myeloma 2 Sarcoma 1 Primary Myelofibrosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Large B-Cell, Diffuse 1 Endometrial Neoplasms 1

Interventions

venetoclax 1 selinexor 1 ruxolitinib 1 navitoclax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07215832 2026-03-02

KEAP

Karyopharm Therapeutics Inc

GynecologicLymphoidMyeloidPlasma cellSarcoma

Multiple Myeloma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Endometrial Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡